Suchergebnisse - "Xu, Xiaowei"

PubPharm (20)

1

Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions : A Consensus Statement

enthalten in: JAMA network open | 2023

von Barnhill, R. | Elder, D. | Piepkorn, M. | +31

2

Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics

enthalten in: Nature immunology | 2022

von Giles, J. | Ngiow, S. | Manne, S. | +17

3

Inactivation of the Hippo tumor suppressor pathway promotes melanoma

enthalten in: Nature communications | 2022

von Vittoria, M. | Kingston, N. | Kotynkova, K. | +12

4

Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma

enthalten in: Oncogene | 2021

von Wang, B. | Zhang, W. | Zhang, G. | +19

5

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment

enthalten in: Nature communications | 2021

von Sun, H. | Cao, S. | Mashl, R. | +147

ErratumIn: Nat Commun. 2022 Jan 7;13(1):294. - PMID 34996889

6

Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy

enthalten in: Nature communications | 2021

von Somasundaram, R. | Connelly, T. | Choi, R. | +54

CommentIn: J Cancer Biol. 2021;2(2):42-43. - PMID 36283004

7

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

enthalten in: Nature genetics | 2021

von Woo, X. | Giordano, J. | Srivastava, A. | +161

ErratumIn: Nat Genet. 2021 May;53(5):761. - PMID 33608693

8

Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors

enthalten in: Cancer immunology research | 2020

von Teh, J. | Erkes, D. | Cheng, P. | +8

9

Subresidue-Resolution Footprinting of Ligand-Protein Interactions by Carbene Chemistry and Ion Mobility-Mass Spectrometry

enthalten in: Analytical chemistry | 2020

von Lu, G. | Xu, X. | Li, G. | +9

10

Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control

enthalten in: Cancer immunology research | 2019

von Sanseviero, E. | O'Brien, E. | Karras, J. | +16